Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125756622 | 12575662 | 2 | F | 2012 | 20160601 | 20160720 | 20160728 | EXP | US-ASTRAZENECA-2016SE59564 | ASTRAZENECA | 68.00 | YR | F | Y | 90.70000 | KG | 20160728 | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125756622 | 12575662 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 10 | MG | TABLET | QD | |||||||
| 125756622 | 12575662 | 2 | SS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | 10 | MG | TABLET | QD | |||||||
| 125756622 | 12575662 | 3 | SS | METOPROLOL TARTRATE. | METOPROLOL TARTRATE | 1 | Oral | 0 | 25 | MG | QD | ||||||||
| 125756622 | 12575662 | 4 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Oral | 0 | 5 | MG | QD | ||||||||
| 125756622 | 12575662 | 5 | C | LOSARTAN AND HYDROCHLOROTHIAZIDE | HYDROCHLOROTHIAZIDELOSARTAN POTASSIUM | 1 | Oral | 0 | 125 | MG | QD | ||||||||
| 125756622 | 12575662 | 6 | C | DULOXETINE HCL | DULOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 90 | MG | QD | ||||||||
| 125756622 | 12575662 | 7 | C | DULOXETINE HCL | DULOXETINE HYDROCHLORIDE | 1 | Oral | 0 | 90 | MG | QD | ||||||||
| 125756622 | 12575662 | 8 | C | BABY ASPIRIN | ASPIRIN | 1 | Oral | 0 | 81 | MG | QD | ||||||||
| 125756622 | 12575662 | 9 | C | HUMALOG | INSULIN LISPRO | 1 | 25 UNITS | 0 | |||||||||||
| 125756622 | 12575662 | 10 | C | TRULICITY | DULAGLUTIDE | 1 | 0 | .75 | MG | /wk | |||||||||
| 125756622 | 12575662 | 11 | C | TOUJEO | INSULIN GLARGINE | 1 | 50 UNITS | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125756622 | 12575662 | 1 | Blood cholesterol increased |
| 125756622 | 12575662 | 2 | Blood cholesterol increased |
| 125756622 | 12575662 | 3 | Cardiac disorder |
| 125756622 | 12575662 | 4 | Blood pressure measurement |
| 125756622 | 12575662 | 5 | Blood pressure measurement |
| 125756622 | 12575662 | 6 | Depression |
| 125756622 | 12575662 | 7 | Fibromyalgia |
| 125756622 | 12575662 | 9 | Blood glucose increased |
| 125756622 | 12575662 | 10 | Blood glucose increased |
| 125756622 | 12575662 | 11 | Diabetes mellitus inadequate control |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125756622 | 12575662 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125756622 | 12575662 | Arterial occlusive disease | |
| 125756622 | 12575662 | Drug dose omission | |
| 125756622 | 12575662 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125756622 | 12575662 | 1 | 2001 | 0 | ||
| 125756622 | 12575662 | 2 | 201603 | 0 | ||
| 125756622 | 12575662 | 3 | 201603 | 0 | ||
| 125756622 | 12575662 | 5 | 2015 | 0 | ||
| 125756622 | 12575662 | 6 | 201603 | 0 | ||
| 125756622 | 12575662 | 7 | 201603 | 0 | ||
| 125756622 | 12575662 | 8 | 2011 | 0 | ||
| 125756622 | 12575662 | 11 | 201605 | 0 |